CDKN2A and cervical cancer: In this process, mutations in PIK3CA and the PI3K/Akt/mTOR signaling pathway play important roles.[26,27] Some studies suggest that mutations in TP53, PIK3CA, and CDKN2A may be associated with the pathogenesis of HPV-negative cervical cancer.[9–12]